63.21 -0.01 (-0.02%)
After hours: 5:30PM EDT
|Bid||63.07 x 1200|
|Ask||63.21 x 300|
|Day's Range||62.88 - 63.31|
|52 Week Range||58.29 - 66.80|
|PE Ratio (TTM)||34.23|
|Earnings Date||Oct 27, 2017|
|Dividend & Yield||1.88 (2.85%)|
|1y Target Est||69.60|
"Prescription drug prices are out of control. The drug prices have gone through the roof," Trump says at a Cabinet meeting.
After months of headlines about astronomical drug prices, a funny thing’s happening — drug costs are plummeting.
To help support innovation in cancer research, Merck , known as MSD outside the United States and Canada, today announced that the company will make a $3 million charitable contribution to Swim Across America.
Merck , known as MSD outside of the United States and Canada, today announced a collaboration with the American Liver Foundation to raise awareness among U.S. veterans about their increased risk for chronic hepatitis C virus infection.
The first placebo-controlled study of two vaccines against the Ebola virus found they both successfully created a powerful antibody response for a year, suggesting they both could be tools to save lives ...
Merck , known as MSD outside the U.S. and Canada, today announced that the company will not submit applications for regulatory approval for anacetrapib, Merck’s investigational cholesteryl ester transfer protein inhibitor.
Merck , known as MSD outside of the United States and Canada, announced results from final analyses of the pivotal Phase III efficacy, immunogenicity, and safety clinical trial for GARDASIL® 9 .
LONDON, UK / ACCESSWIRE / October 5, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Merck & Co., Inc. (NYSE: MRK ) ("Merck"), following ...
Global Healthcare Investment Advisors LLC wants to generate more than just healthy financial returns with its deals. The New York-based firm, which does business as the Global Health Investment Fund, also ...
Merck , known as MSD outside the United States and Canada, today announced that researchers will provide 40 scientific data presentations on the company’s established and investigational infectious disease medicines and vaccines at ID Week 2017 in San Diego from Oct.
Merck , known as MSD outside of the United States and Canada, today announced that data from the company’s chronic hepatitis C clinical development programs and real-world studies are scheduled to be presented at The Liver Meeting® 2017.
Merck (MRK) is discontinuing the development of two of its hepatitis C (HCV) programs - MK-3682B and MK-3682C - as the HCV market is becoming extremely crowded.
Merck & Co. is halting development of new hepatitis C treatments after reviewing their effectiveness and determining an abundance of treatments were already available.
Bristol-Myers Squibb (BMY), a US pharmaceutical company, includes innovative products from its Cardiovascular, Immunoscience, Neuroscience, Oncology, and Virology franchises.
Ligand's (LGND) Captisol formulation technology platform allows it to partner with several leading drug companies, thus helping it earn milestones and royalty payments in turn.
Merck & Co. said Friday it would discontinue the development of the investigational combination regimens MK-3682B and MK-3682C for the treatment of chronic hepatitis C, after a review of available Phase ...